Haleon FDA Wednesday, January 14, 1998 0.00 Neutral

FDA Approves EXCEDRIN MIGRAINE GELTABS — Haleon US Holdings LLC

Excedrin Migraine GelTabs has been approved by the U.S. Food and Drug Administration, with Haleon US Holdings LLC now overseeing the oral acetaminophhen Aspirin Caffeine product backed by a 1998 application. This decision is expected to bolster Haleon's leading migraine portfolio by maintaining its stronghold over this widely relied-upon combination therapy.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed